Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Aridis Pharmaceuticals, Inc. (ARDS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/25/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/29/2019 |
4/A
| Truong Vu (CEO, CSO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options
@ $0 |
|
| 08/29/2019 |
4/A
| KURLAND FRED (CFO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options
@ $8.5, valued at
$144.5k
|
|
| 08/29/2019 |
4/A
| Dummer Wolfgang (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options
@ $8.5, valued at
$212.5k
|
|
| 08/29/2019 |
4/A
| Windham-Bannister Susan Richards (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options
@ $10.01, valued at
$350.4k
|
|
| 12/12/2018 |
4/A
| KURLAND FRED (CFO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options
@ $8.5, valued at
$144.5k
|
|
|
|